FR2804430B1 - 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION - Google Patents

4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Info

Publication number
FR2804430B1
FR2804430B1 FR0001098A FR0001098A FR2804430B1 FR 2804430 B1 FR2804430 B1 FR 2804430B1 FR 0001098 A FR0001098 A FR 0001098A FR 0001098 A FR0001098 A FR 0001098A FR 2804430 B1 FR2804430 B1 FR 2804430B1
Authority
FR
France
Prior art keywords
diazabicyclo
heteroaryl
preparation
therapeutic application
nonane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0001098A
Other languages
French (fr)
Other versions
FR2804430A1 (en
Inventor
Frederic Galli
Samir Jegham
Odile Leclerc
Alistair Lochead
Alain Nedelec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0001098A priority Critical patent/FR2804430B1/en
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to DE60100621T priority patent/DE60100621T2/en
Priority to AT01907686T priority patent/ATE247658T1/en
Priority to EP01907686A priority patent/EP1254139B1/en
Priority to JP2001561009A priority patent/JP4759199B2/en
Priority to PCT/FR2001/000227 priority patent/WO2001055150A1/en
Priority to AU2001235595A priority patent/AU2001235595A1/en
Priority to US10/181,870 priority patent/US6835730B2/en
Priority to ARP010100341A priority patent/AR027296A1/en
Publication of FR2804430A1 publication Critical patent/FR2804430A1/en
Application granted granted Critical
Publication of FR2804430B1 publication Critical patent/FR2804430B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FR0001098A 2000-01-28 2000-01-28 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION Expired - Fee Related FR2804430B1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0001098A FR2804430B1 (en) 2000-01-28 2000-01-28 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
AT01907686T ATE247658T1 (en) 2000-01-28 2001-01-24 4-HETEROARYL-1,4-DIAZABICYCLO 3.2.2.)NONANES, THEIR PRODUCTION AND THEIR THERAPEUTIC APPLICATION
EP01907686A EP1254139B1 (en) 2000-01-28 2001-01-24 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
JP2001561009A JP4759199B2 (en) 2000-01-28 2001-01-24 4-Heteroaryl-1,4-diazabicyclo [3.2.2] -nonane derivatives, their preparation and therapeutic use
DE60100621T DE60100621T2 (en) 2000-01-28 2001-01-24 4-HETEROARYL-1,4-DIAZABICYCLO 3.2.2.] NONANESE, THEIR MANUFACTURE AND ITS THERAPEUTIC APPLICATION
PCT/FR2001/000227 WO2001055150A1 (en) 2000-01-28 2001-01-24 4-heteroaryl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
AU2001235595A AU2001235595A1 (en) 2000-01-28 2001-01-24 4-heteroaryl-1,4-diazabicyclo(3.2.2)nonane, preparation and therapeutic use thereof
US10/181,870 US6835730B2 (en) 2000-01-28 2001-01-24 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
ARP010100341A AR027296A1 (en) 2000-01-28 2001-01-26 DERIVATIVES OF 4-HETEROARIL-1,4-DIAZABICICLO [3.2.2] NONANO, ITS PREPARATION AND THERAPEUTIC APPLICATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0001098A FR2804430B1 (en) 2000-01-28 2000-01-28 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (2)

Publication Number Publication Date
FR2804430A1 FR2804430A1 (en) 2001-08-03
FR2804430B1 true FR2804430B1 (en) 2002-03-22

Family

ID=8846415

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0001098A Expired - Fee Related FR2804430B1 (en) 2000-01-28 2000-01-28 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Country Status (9)

Country Link
US (1) US6835730B2 (en)
EP (1) EP1254139B1 (en)
JP (1) JP4759199B2 (en)
AR (1) AR027296A1 (en)
AT (1) ATE247658T1 (en)
AU (1) AU2001235595A1 (en)
DE (1) DE60100621T2 (en)
FR (1) FR2804430B1 (en)
WO (1) WO2001055150A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (en) 2001-12-27 2003-07-10 Bayer Ag 2-heteroaryl carboxamides
FR2840896B1 (en) * 2002-06-18 2005-04-08 Sanofi Synthelabo PHENYL AND PYRIDYL PIPERAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
BR0314201A (en) 2002-09-10 2005-07-12 Pfizer Prod Inc Diazabicyclic Compounds Useful in the Treatment of CNS Diseases and Other Disorders
ATE426602T1 (en) * 2002-09-30 2009-04-15 Neurosearch As 1,4-DIAZABICYCLOACANDERIVATES, THEIR PREPARATION AND USE
RU2323218C2 (en) * 2002-09-30 2008-04-27 НьюроСёрч А/С Novel derivatives of 1,4-diazabicycloalkane and pharmaceutical composition based on thereof
FR2845388B1 (en) * 2002-10-08 2004-11-12 Sanofi Synthelabo 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
US7456171B2 (en) 2002-10-08 2008-11-25 Sanofi-Aventis 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof
WO2004076453A1 (en) * 2003-02-27 2004-09-10 Neurosearch A/S Novel diazabicyclic aryl derivatives
CA2555311A1 (en) * 2004-02-04 2005-08-18 Neurosearch A/S Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
EP2190846A1 (en) * 2007-08-17 2010-06-02 Neurosearch A/S 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands
CN101855223A (en) 2007-11-14 2010-10-06 神经研究公司 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
CN105687190A (en) 2008-11-19 2016-06-22 福拉姆医药股份有限公司 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
RU2011150248A (en) * 2009-05-11 2013-06-20 Энвиво Фармасьютикалз, Инк. TREATMENT OF COGNITIVE DISORDERS WITH SPECIFIC ALPHA-7 NICOTIN ACID RECEPTORS IN COMBINATION WITH ACETYLCHOLINESTERASE INHIBITORS
TWI558398B (en) 2009-09-22 2016-11-21 諾華公司 Use of nicotinic acetylcholine receptor alpha 7 activators
AU2011256287B2 (en) 2010-05-17 2016-11-10 Envivo Pharmaceuticals, Inc. A crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
TW201311698A (en) * 2011-08-22 2013-03-16 Targacept Inc 1,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands
RU2017136693A (en) 2012-05-08 2019-02-08 Форум Фармасьютикалз, Инк. METHODS FOR MAINTAINING, TREATING OR IMPROVING COGNITIVE FUNCTION
CN105906563B (en) * 2014-11-10 2019-01-22 苏州康润医药有限公司 The synthetic method of 7,8- difluoro-quinoline -3- formic acid
CN104447547B (en) * 2014-11-10 2017-04-19 苏州康润医药有限公司 Synthesis method of 4-aminoisoquinoline-8-methyl formate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478939A (en) * 1994-07-20 1995-12-26 American Cyanamid Company (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
SE9600683D0 (en) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
FR2786770B1 (en) * 1998-12-04 2001-01-19 Synthelabo NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2786769B1 (en) * 1998-12-04 2002-10-25 Synthelabo 2,5-DIAZABICYCLO [2.2.1] HEPTANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
DE60100621T2 (en) 2004-06-17
AU2001235595A1 (en) 2001-08-07
AR027296A1 (en) 2003-03-19
US20030119840A1 (en) 2003-06-26
DE60100621D1 (en) 2003-09-25
ATE247658T1 (en) 2003-09-15
JP2003523359A (en) 2003-08-05
WO2001055150A1 (en) 2001-08-02
US6835730B2 (en) 2004-12-28
EP1254139B1 (en) 2003-08-20
FR2804430A1 (en) 2001-08-03
EP1254139A1 (en) 2002-11-06
JP4759199B2 (en) 2011-08-31

Similar Documents

Publication Publication Date Title
FR2786770B1 (en) NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2791678B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANE-4-CARBOXYLATES AND -CARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2790474B1 (en) PYRIDOPYRANOAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2804430B1 (en) 4-HETEROARYL-1,4-DIAZABICYCLO [3.2.2] NONANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
MA27049A1 (en) 1-PHENYLSULFONYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2786769B1 (en) 2,5-DIAZABICYCLO [2.2.1] HEPTANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2832713B1 (en) DERIVATIVES OF 4- (1,3,4-THIADIAZOL-2-YL) -1,4-DIAZABICYCLO [3.2.2] NONANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2809730B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANEBENZOXAZOLE, -BENZOTHIAZOLE AND -BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2809732B1 (en) DERIVATIVES OF 4 (-2-PHENYLTHIAZOL-5-yl) -1,4-DIAZABICYCLO- [3.2.2] NONANE, THEIR PREPARATION AND THEIR THERAPY APPLICATION
FR2843964B1 (en) DIOXANE-2-ALKYLCARBAMATES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2832712B1 (en) DERIVATIVES OF 4- (OXADIAZOL-3-YL) -1,4-DIAZABICYCLO [3.2.2] NONANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2809731B1 (en) 1,4-DIAZABICYCLO- [3.2.2] NONANE-PHEYLISOXAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
MA27233A1 (en) PIPERAZINYLACYLPIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2728900B1 (en) 3-PHENYLISOQUINOLEIN-1 (2H) -ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2756563B1 (en) 1,4-DIAZABICYCLO [2.2.2] OCT-2-YL-METHYL BENZOATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2766823B1 (en) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO [4,5-B] INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2845388B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2792318B1 (en) INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2788776B1 (en) DERIVATIVES OF 4-OXO-3, 5-DIHYDRO-4H-PYRIDAZINO [4,5-B] INDOLE-1 -CARBOXAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2806722B1 (en) N- (HETEROCYCLYLBUTYL) BENZENE- OR PYRIDINE SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2765874B1 (en) 6-PYRROLIDIN-2-YLPYRINDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2761070B1 (en) DIHYDROPYRAZINO [1,2-A] INDOLE-1-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2792635B1 (en) CYCLOBUTENE-3,4-DIONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2805815B1 (en) POLYFLUOROALKYLIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2785903B1 (en) 1-AMINOETHYLQUINOLEINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

ST Notification of lapse

Effective date: 20180928